Asthma in Children With Melanocortin 4 Receptor (MC4R) Gene Mutation Variant: A Case Series

Haitham Al-Dhmour1, Mahmoud Abu Zahra1, Deepa Rastogi1

  • 1Division of Pediatric Respiratory and Sleep Medicine, The Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York, USA.

Pediatric Pulmonology
|April 7, 2026
PubMed
Abstract

Insights

Melanocortin 4 receptor (MC4R) gene mutations, a common cause of childhood obesity, may be linked to asthma. This study observed asthma in children with MC4R variants and obesity, suggesting a potential association.

Area of Science:

  • Genetics
  • Pediatrics
  • Pulmonology

Background:

  • Melanocortin 4 receptor (MC4R) gene mutations are the leading genetic cause of non-syndromic obesity in children.
  • The connection between MC4R mutations and asthma has not been previously established.

Purpose of the Study:

  • To investigate the potential association between MC4R gene mutations and asthma in pediatric patients.
  • To describe the clinical presentation of asthma in children with MC4R-related obesity.

Main Methods:

  • Case series reporting on four children with a shared MC4R gene variant.
  • Clinical data including asthma characteristics, obesity, and comorbidities were reviewed.

Main Results:

  • All four children with the MC4R variant presented with asthma alongside obesity.
  • Asthma presentation and severity varied among the patients.
  • Comorbidities such as obstructive sleep apnea (OSA), insulin resistance, and hypertension were present in some patients.

Conclusions:

  • MC4R mutations and associated severe obesity appear to be linked with asthma in children.
  • Further research is needed to elucidate the biological mechanisms connecting MC4R mutations, obesity, and asthma.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K